Test Price
2,800 AED✅ Home Collection Available
GNE Gene Inclusion Body Myopathy Genetic Test in UAE – 2800 AED – DHA Licensed
Executive Summary & Core Metrics
Clinical Assurance & Service Highlights
- ◆ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing with orthogonal Sanger confirmation of all pathogenic and likely pathogenic variants.
- ◆ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — available daily from 8 AM to 11 PM across all seven Emirates.
- ◆ Clinical Guidance: Telephonic post-test consultation with a DHA-licensed Consultant Medical Geneticist to interpret results and discuss clinical implications.
- ◆ Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731 — pre-authorization assistance for all major UAE health insurers.
Test Overview & Methodology
The GNE Gene Inclusion Body Myopathy Genetic Test is a definitive molecular diagnostic assay that sequences all coding exons and flanking intronic regions of the GNE gene (UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase) to identify pathogenic variants causative of GNE Myopathy, also known as Inclusion Body Myopathy Type 2 (IBM2) or Nonaka Myopathy. Next Generation Sequencing (NGS) technology is employed with 100x mean depth, and all clinically relevant variants are confirmed by Sanger sequencing to ensure 99.9% analytical sensitivity.
| Parameter | Our Test – GNE NGS (Full Gene) | Closest Alternative – Targeted GNE Panel / Sanger |
|---|---|---|
| Diagnostic Precision | >99.9% — Full gene coverage with 100x mean depth | ~95% — Limited to known hotspot variants or select exons |
| Methodology | NGS (Next Generation Sequencing) + Orthogonal Sanger Confirmation | Sanger Sequencing (single-exon) or Limited NGS Panel |
| Variant Detection | SNVs, Indels, Splice-Site Variants — Full Coding Region | Pre-selected exons only; may miss novel or deep intronic variants |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (fragmented send-out testing) |
| Clinical Report | DHA-Compliant, Clinically Annotated, ACMG Classified | Variable — may lack UAE-specific regulatory annotation |
| Price | 2800 AED — All-Inclusive | 2500–3500 AED (often excludes counselling or confirmation) |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist with extensive experience in neuromuscular disorders, I emphasize that a positive GNE variant finding provides a molecular confirmation that must be interpreted within the full clinical phenotype, EMG findings, and muscle biopsy histology. A negative result does not exclude GNE myopathy if deep intronic or copy-number variations are present beyond the resolution of standard NGS. Every report is reviewed by a dual-specialist team to ensure accurate classification and actionable guidance."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
⚠ Medication Safety Advisory
Do not discontinue prescribed medication without consulting your doctor. This genetic test is a diagnostic tool — it does not replace ongoing neurological care, physiotherapy, or pharmacologic management. Abrupt cessation of prescribed supportive therapy (including immunosuppressants, sialic acid precursors under clinical trial protocols, or physiotherapy regimens) may precipitate accelerated disease progression.
Exclusion Criteria & Emergency Red Flags
- ⛔ Exclusion — Minors Without Consent: Genetic testing of individuals below 18 years requires documented, witnessed consent from a legal guardian. Unsolicited testing of minors is strictly prohibited under UAE Federal Law No. 2 of 2019.
- ⛔ Exclusion — Inadequate Pre-Test Counselling: All patients must undergo a genetic counselling session with pedigree chart documentation prior to sample collection. Specimens received without counselling records will be placed on hold.
- ⛔ Exclusion — Recent Blood Transfusion: Whole blood samples collected within 4 weeks of a packed red cell or whole blood transfusion may yield chimeric results. Use buccal swab or FTA card alternative if transfusion history is recent.
- 🚨 ER Red Flag — Acute Respiratory Distress: Patients with GNE myopathy presenting with sudden-onset dyspnoea or orthopnoea must seek emergency medical evaluation immediately for possible diaphragmatic involvement — do not await genetic test results.
- 🚨 ER Red Flag — Severe Dysphagia: Progressive swallowing difficulty with aspiration risk requires urgent otolaryngology or gastroenterology assessment independent of genetic testing status.
Patient FAQ & Clinical Guidance
1. What exactly does the GNE Gene NGS test detect, and how is it different from a muscle biopsy?
Snippet Answer: The GNE Gene NGS test directly sequences your entire GNE gene from a blood sample to identify disease-causing mutations at the DNA level with 99.9% sensitivity — unlike a muscle biopsy, which examines tissue damage microscopically after it has occurred.
GNE Myopathy (Nonaka Myopathy) is caused by biallelic pathogenic variants in the GNE gene on chromosome 9p13.3. This NGS test reads every coding nucleotide of the gene, detecting single-nucleotide variants, small insertions/deletions, and splice-site mutations. A muscle biopsy, while valuable for showing rimmed vacuoles and tubulofilamentous inclusions, is an invasive procedure that demonstrates structural damage — it does not identify the specific genetic mutation. Molecular diagnosis via NGS is the gold standard per current ACMG guidelines for hereditary myopathies, enabling precise genetic counselling, family cascade screening, and eligibility assessment for emerging sialic acid replacement therapies.
2. How should I prepare for the blood draw, and are there any medications I must stop?
Snippet Answer: No fasting or medication discontinuation is required for the GNE gene blood draw — continue all prescribed medications unless your neurologist specifically instructs otherwise during your pre-test consultation.
The sample requirement is straightforward: 3–5 mL of whole blood collected in an EDTA (lavender-top) tube, or alternatively, a dried blood spot on an FTA card via finger-prick. There is no need to withhold food, fluids, or routine medications. Critically, immunosuppressants, corticosteroids, or any investigational agents (including sialic acid or ManNAc supplements) must be continued as prescribed — interrupting these can destabilize muscle function. Our home collection phlebotomist will verify your medication list and note any relevant exposures. The pre-test genetic counselling session (mandatory per UAE health regulations) will also review your full clinical history and construct a family pedigree chart.
3. What happens after I receive my results, and how long until I get them?
Snippet Answer: Your comprehensive GNE gene report is delivered within 3 to 4 weeks and includes a telephonic post-test consultation where a DHA-licensed Consultant Medical Geneticist explains every finding in plain clinical language.
Upon completion of sequencing and bioinformatic analysis, all identified variants are classified according to the ACMG/AMP five-tier system: Pathogenic, Likely Pathogenic, Variant of Uncertain Significance (VUS), Likely Benign, or Benign. The report clearly states whether biallelic pathogenic variants were identified (confirming GNE myopathy), a single heterozygous variant was found (carrier status), or no clinically relevant variants were detected. Each report undergoes dual-review by a clinical molecular geneticist and a consultant neurologist. The included telephonic post-test guidance session — scheduled within 72 hours of report release — walks you through the implications for your diagnosis, family planning, and treatment eligibility. All genomic data is stored securely under UAE PDPL encryption standards with restricted access protocols.
4. Does health insurance in the UAE cover the 2800 AED cost of the GNE gene test?
Snippet Answer: Yes, many major UAE health insurers cover the GNE gene test when ordered by a consultant neurologist with adequate clinical documentation — our team verifies coverage directly via WhatsApp.
We coordinate directly with insurers including Daman, AXA, Mednet, Medgulf, MetLife, and Nextcare to verify genetic test coverage. Most policies require a referral from a neurologist or clinical geneticist with a medical report documenting clinical symptoms of myopathy. For a coverage inquiry, please contact us via WhatsApp at +971 54 548 8731 with a copy of your insurance card and doctor's referral.
UAE Regulatory & Data Privacy Adherence
Compliance & Accreditation Framework
Clinical & Logistical Metadata
| Test Name | GNE Gene Inclusion Body Myopathy Genetic Test (NGS) |
| Price (AED) | 2,800 AED (all-inclusive, no hidden fees) |
| Turnaround Time | 3 to 4 weeks from sample receipt at laboratory |
| Sample Type / Matrix | Whole Blood (EDTA tube) or Dried Blood Spot (FTA card) |
| Methodology Used | Next Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | G71.0 |
| LOINC Code | 21665-7 |
| DHA Facility License & Laboratory Address | DHA License 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
Schedule Your GNE Gene NGS Test – Home Collection Across All UAE Emirates
DHA-Licensed Mobile Phlebotomy | ISO 9001:2015 Certified | 3–4 Week TAT | 2800 AED
Available 8:00 AM – 11:00 PM GST | Pre-test Genetic Counselling Mandatory | Insurance Verification via WhatsApp
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians